These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36232368)

  • 21. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mixed dementia: the role of cerebrovascular pathology].
    Tabeeva GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):111-116. PubMed ID: 30335082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular cognitive impairment: dementia biology and translational animal models.
    Barone FC; Rosenbaum DM; Zhou J; Crystal H
    Curr Opin Investig Drugs; 2009 Jul; 10(7):624-37. PubMed ID: 19579168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modern concept of vascular cognitive impairment.
    Bowler JV
    Br Med Bull; 2007; 83():291-305. PubMed ID: 17675645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vascular cognitive impairment].
    Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):17-23. PubMed ID: 36279224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study.
    Sachdev PS; Lipnicki DM; Crawford JD; Brodaty H
    Eur J Neurol; 2019 Sep; 26(9):1161-1167. PubMed ID: 30927497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From neuronal and vascular impairment to dementia.
    De Deyn PP; Goeman J; Engelborghs S; Hauben U; D'Hooge R; Baro F; Pickut BA
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():17-24. PubMed ID: 10338104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia.
    Graham NL; Emery T; Hodges JR
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):61-71. PubMed ID: 14707310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group.
    Perneczky R; Tene O; Attems J; Giannakopoulos P; Ikram MA; Federico A; Sarazin M; Middleton LT
    BMC Med; 2016 Nov; 14(1):162. PubMed ID: 27806707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is drug use by the elderly with cognitive impairment influenced by type of dementia?
    Gambassi G; Landi F; Lapane KL; Sgadari A; Mor V; Bernabei R
    Pharmacotherapy; 1999 Apr; 19(4):430-6. PubMed ID: 10212014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General measures of cognition.
    Ferris SH
    Int Psychogeriatr; 2003; 15 Suppl 1():215-7. PubMed ID: 16191243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Models and mechanisms of vascular dementia.
    Venkat P; Chopp M; Chen J
    Exp Neurol; 2015 Oct; 272():97-108. PubMed ID: 25987538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular Cognitive Impairment and Dementia.
    Chang Wong E; Chang Chui H
    Continuum (Minneap Minn); 2022 Jun; 28(3):750-780. PubMed ID: 35678401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2000; 2002(2):CD000147. PubMed ID: 10796495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinpocetine for cognitive impairment and dementia.
    Szatmari SZ; Whitehouse PJ
    Cochrane Database Syst Rev; 2003; 2003(1):CD003119. PubMed ID: 12535455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.